MD2852C2 - Использование будесонида для лечения резистентного асцита у больных с циррозом печени - Google Patents

Использование будесонида для лечения резистентного асцита у больных с циррозом печени Download PDF

Info

Publication number
MD2852C2
MD2852C2 MDA20050089A MD20050089A MD2852C2 MD 2852 C2 MD2852 C2 MD 2852C2 MD A20050089 A MDA20050089 A MD A20050089A MD 20050089 A MD20050089 A MD 20050089A MD 2852 C2 MD2852 C2 MD 2852C2
Authority
MD
Moldova
Prior art keywords
budesonide
treatment
hepatic cirrhosis
pacients
resistant ascites
Prior art date
Application number
MDA20050089A
Other languages
English (en)
Romanian (ro)
Other versions
MD2852B1 (en
Inventor
Георге АНГЕЛИЧ
Константин ЦЫБЫРНЭ
Виорел МОРАРУ
Лариса ПРОКОПИШИНА
Раду КРУДУ
Original Assignee
Георге АНГЕЛИЧ
Константин ЦЫБЫРНЭ
САМОХВАЛОВ Сергей
Лариса ПРОКОПИШИНА
КРУДУ Олег
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге АНГЕЛИЧ, Константин ЦЫБЫРНЭ, САМОХВАЛОВ Сергей, Лариса ПРОКОПИШИНА, КРУДУ Олег filed Critical Георге АНГЕЛИЧ
Priority to MDA20050089A priority Critical patent/MD2852C2/ru
Publication of MD2852B1 publication Critical patent/MD2852B1/xx
Publication of MD2852C2 publication Critical patent/MD2852C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, в частности к гепатологии.Сущность изобретения состоит в использовании будесонида для лечения резистентного асцита у больных с декомпенсированным циррозом печени.Результат изобретения состоит в уменьшении регионального хронического воспалительного процесса за счет уменьшения проницаемости сосудистой стенки и транссудации жидкости в интерстициальном пространстве органов брюшной полости и предотвращает ее накопление в перитонеальной полости, которая ведет к формированию резистентного асцита.
MDA20050089A 2005-03-28 2005-03-28 Использование будесонида для лечения резистентного асцита у больных с циррозом печени MD2852C2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050089A MD2852C2 (ru) 2005-03-28 2005-03-28 Использование будесонида для лечения резистентного асцита у больных с циррозом печени

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050089A MD2852C2 (ru) 2005-03-28 2005-03-28 Использование будесонида для лечения резистентного асцита у больных с циррозом печени

Publications (2)

Publication Number Publication Date
MD2852B1 MD2852B1 (en) 2005-09-30
MD2852C2 true MD2852C2 (ru) 2006-04-30

Family

ID=35057532

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050089A MD2852C2 (ru) 2005-03-28 2005-03-28 Использование будесонида для лечения резистентного асцита у больных с циррозом печени

Country Status (1)

Country Link
MD (1) MD2852C2 (ru)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19742612A1 (de) * 1997-09-26 1999-04-01 Falk Pharma Gmbh Budesonid zur Behandlung von cholestatischen Lebererkrankungen
WO1999039699A1 (en) * 1998-02-09 1999-08-12 Rtp Pharma, Inc. Treatment of chronic inflammatory disorders of the gastrointestinal tract

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19742612A1 (de) * 1997-09-26 1999-04-01 Falk Pharma Gmbh Budesonid zur Behandlung von cholestatischen Lebererkrankungen
WO1999039699A1 (en) * 1998-02-09 1999-08-12 Rtp Pharma, Inc. Treatment of chronic inflammatory disorders of the gastrointestinal tract

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Spencer C., Mc. Tavish D. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs, 1995, vol. 50, p. 854-872 *

Also Published As

Publication number Publication date
MD2852B1 (en) 2005-09-30

Similar Documents

Publication Publication Date Title
FR25C1043I1 (fr) Utilisation de citrate ferrique dans le traitement de patients atteints d'une maladie rénale chronique
EP2760371A4 (en) VENTRICULAR TRANSCATHETER RECONSTRUCTION STRUCTURES, METHODS AND SYSTEMS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER SUFFERING
TR201818927T4 (tr) Kataterlerde İyileştirme
SG11201504463SA (en) Combination double-barreled and debranching stent grafts
EP3687394A4 (en) CATHETER POSITIONING IN PEDIATRIC PATIENTS
PH12018502593A1 (en) Combinations of linagliptin and metformin
MX2015013944A (es) Inhibidor de quinasa.
EP1662965A4 (en) FORMULATIONS AND METHOD FOR THE TREATMENT OF BREAST CANCER WITH MORINDA CITRIFOLIA AND METHYLSULFONYLMETHANE
WO2013022567A3 (en) Vascular filter
EP2182978A4 (en) TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN
FR3005564B1 (fr) Instrument destine a etre utlise pour modifier le volume de l'estomac d'un patient.
EP2148675A4 (en) ANTI-CANCER FOR THE DIAGNOSIS AND TREATMENT OF CANCER
FR2919060B1 (fr) Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
EP4279925A3 (en) Dulaglutide for the treatment of chronic kidney disease
JP2010209101A5 (ru)
MX2015001508A (es) El uso de antitrombina en la oxigenacion por membrana extracorporea.
EP2185162A4 (en) POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES
WO2007023154A3 (de) EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG
de Franciscis et al. Matrix metalloproteinases and endothelial dysfunction: the search for new prognostic markers and for new therapeutic targets for vascular wall imbalance
EP2170351A4 (en) METHOD AND COMPOSITION FOR TREATING CANCER AND OTHER ANGIOGENESIS-MEDIATED ILLNESSES
EP2470217A4 (en) OBJECT TO PAX2 FOR THE TREATMENT OF BREAST CANCER
EP2455079A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES WITH COLFORSINE DAROPATE
EP1889618A4 (en) Combined drug for treating diabetes
MD2852B1 (en) Use of budesonide for treatment of resistant ascites to pacients with hepatic cirrhosis
EP2136820A4 (en) TARGET FOR BREAST CANCER THERAPY AND / OR DIAGNOSIS

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees